Survival of San Diego cinema during pandemic

Credit: ABC 10 News | San Diego

Duration: 02:14s 05 Oct 2020 0 shares 3 views

Survival of San Diego cinema during pandemic

Regal Cinemas face possible closures while locally owned outdoor movie theater thriving.

Advertisement

Related news coverage

UPDATE - Ecwid Announces New Payments Partnerships, Accelerating Record Growth Across Europe

GlobeNewswire 17 Dec 2020

More than 140% YoY increase in new customers and transaction volume fuel company growth and strengthen leadership..

Ecwid Announces New Payments Partnerships, Accelerating Record Growth Across Europe
GlobeNewswire 17 Dec 2020
Senhwa Biosciences's Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium
PR Newswire Asia 14 Dec 2020
TRACON Announces Publication in Cancer Cell of Clinical Data that Provides Molecular Insight into the Mechanism of Action of TRC102 and Patient Populations Most Likely to Respond to Treatment
GlobeNewswire 23 Nov 2020
Support Black Small Businesses This Holiday Season By Giving The Gift Of Health - Beymoss.com
GlobeNewswire 21 Nov 2020

You might like

More coverage

San Diego gyms brace for COVID-19 purple tier changes

San Diego gyms brace for COVID-19 purple tier changes

ABC 10 News | San Diego 12 Nov 2020

It's survival of the fittest once again for gyms and fitness centers across the county as San Diego braces for stricter..

For Top Restaurants, a Localized Digital Presence is Key to Survive the Pandemic, According to Research from SOCi

For Top Restaurants, a Localized Digital Presence is Key to Survive the Pandemic, According to Research from SOCi

Business Wire

19 Nov 2020

Inside Laemmle Theatres’ Struggle to Survive Despite LA’s ‘Stupid’ COVID Rules

Inside Laemmle Theatres’ Struggle to Survive Despite LA’s ‘Stupid’ COVID Rules

The Wrap

29 Oct 2020

TRACON Announces FDA Orphan Drug Designation for TRC102 in Malignant Glioma, Including Glioblastoma
GlobeNewswire 26 Oct 2020
Turning Point Therapeutics Presents Initial Clinical Data From Phase 1 SHIELD-1 Study of Novel MET/SRC/CSF1R Inhibitor TPX-0022 at 2020 EORTC-NCI-AACR Symposium
GlobeNewswire 24 Oct 2020